Rituximab biosimilar dose

Hospital buy vs billed (illustrative WAC/GPO/340B blend) Specialty; biosimilar preferred on formulary

What the hospital pays (acquisition)$3,200

Cash$5,200

Medicaid$3,500

Medicare$4,100

Insured$6,800

Medicaid

$3,500

Medicare

$4,100

Cash

$5,200

Insured

$6,800

Insured path is $1,600 (31%) above cash. Hospital buy $3,200 vs insured $6,800.

Payers: modeled — see evidence.